290 related articles for article (PubMed ID: 34469882)
21. MiR-93 inhibits the vascular calcification of chronic renal failure by suppression of Wnt/β-catenin pathway.
Peng J; Qin C; Tian SY; Peng JQ
Int Urol Nephrol; 2022 Jan; 54(1):225-235. PubMed ID: 34138419
[TBL] [Abstract][Full Text] [Related]
22. Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells.
Choi SY; Ryu HM; Oh EJ; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
PLoS One; 2017; 12(7):e0180393. PubMed ID: 28686724
[TBL] [Abstract][Full Text] [Related]
23. Irisin alleviates vascular calcification by inhibiting VSMC osteoblastic transformation and mitochondria dysfunction via AMPK/Drp1 signaling pathway in chronic kidney disease.
Wang PW; Pang Q; Zhou T; Song XY; Pan YJ; Jia LP; Zhang AH
Atherosclerosis; 2022 Apr; 346():36-45. PubMed ID: 35255258
[TBL] [Abstract][Full Text] [Related]
24. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T
Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165
[TBL] [Abstract][Full Text] [Related]
25. Apelin: A novel inhibitor of vascular calcification in chronic kidney disease.
Han X; Wang LY; Diao ZL; Liu WH
Atherosclerosis; 2016 Jan; 244():1-8. PubMed ID: 26581047
[TBL] [Abstract][Full Text] [Related]
26. The PPAR-γ/SFRP5/Wnt/β-catenin signal axis regulates the dexamethasone-induced osteoporosis.
He HP; Gu S
Cytokine; 2021 Jul; 143():155488. PubMed ID: 33814272
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II prevents calcification in vascular smooth muscle cells by enhancing magnesium influx.
Herencia C; Rodríguez-Ortiz ME; Muñoz-Castañeda JR; Martinez-Moreno JM; Canalejo R; Montes de Oca A; Díaz-Tocados JM; Peralbo-Santaella E; Marín C; Canalejo A; Rodriguez M; Almaden Y
Eur J Clin Invest; 2015 Nov; 45(11):1129-44. PubMed ID: 26268950
[TBL] [Abstract][Full Text] [Related]
28. The WNT/β-catenin system in chronic kidney disease-mineral bone disorder syndrome.
Zhang L; Adu IK; Zhang H; Wang J
Int Urol Nephrol; 2023 Oct; 55(10):2527-2538. PubMed ID: 36964322
[TBL] [Abstract][Full Text] [Related]
29. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
Yamada S; Tatsumoto N; Tokumoto M; Noguchi H; Ooboshi H; Kitazono T; Tsuruya K
Calcif Tissue Int; 2015 Apr; 96(4):347-58. PubMed ID: 25511229
[TBL] [Abstract][Full Text] [Related]
30. Sclerostin is involved in osteogenic transdifferentiation of vascular smooth muscle cells in chronic kidney disease-associated vascular calcification with non-canonical Wnt signaling.
Xiao Q; Tang Y; Luo H; Chen S; Chen R; Yan Z; Pu L; Wang L; Li G; Li Y
Ren Fail; 2022 Dec; 44(1):1426-1442. PubMed ID: 36017689
[TBL] [Abstract][Full Text] [Related]
31. OGT knockdown counteracts high phosphate-induced vascular calcification in chronic kidney disease through autophagy activation by downregulating YAP.
Xu TH; Sheng Z; Li Y; Qiu X; Tian B; Yao L
Life Sci; 2020 Nov; 261():118121. PubMed ID: 32693242
[TBL] [Abstract][Full Text] [Related]
32. BRCC36 prevents vascular calcification in chronic kidney disease through the β-catenin signalling pathway.
Xie C; Chen C; Wu L; Xiong Y; Xing C; Mao H
Exp Cell Res; 2022 Apr; 413(1):113051. PubMed ID: 35149088
[TBL] [Abstract][Full Text] [Related]
33. Erythropoietin attenuates vascular calcification by inhibiting endoplasmic reticulum stress in rats with chronic kidney disease.
Chang JR; Sun N; Liu Y; Wei M; Zhao Y; Gan L; Zhu JX; Su XL
Peptides; 2020 Jan; 123():170181. PubMed ID: 31689455
[TBL] [Abstract][Full Text] [Related]
34. WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression.
Cai T; Sun D; Duan Y; Wen P; Dai C; Yang J; He W
Exp Cell Res; 2016 Jul; 345(2):206-17. PubMed ID: 27321958
[TBL] [Abstract][Full Text] [Related]
35. Elevated Serum SFRP5 Levels During Preeclampsia and Its Potential Association with Trophoblast Dysfunction via Wnt/β-Catenin Suppression.
Zhang Y; Ran Y; Ma Y; Huang H; Chen Y; Qi H
Reprod Sci; 2022 Jan; 29(1):163-172. PubMed ID: 34382203
[TBL] [Abstract][Full Text] [Related]
36. Indoxyl sulfate accelerates vascular smooth muscle cell calcification via microRNA-29b dependent regulation of Wnt/β-catenin signaling.
Zhang H; Chen J; Shen Z; Gu Y; Xu L; Hu J; Zhang X; Ding X
Toxicol Lett; 2018 Mar; 284():29-36. PubMed ID: 29195902
[TBL] [Abstract][Full Text] [Related]
37. Vascular calcification and renal bone disorders.
Lu KC; Wu CC; Yen JF; Liu WC
ScientificWorldJournal; 2014; 2014():637065. PubMed ID: 25136676
[TBL] [Abstract][Full Text] [Related]
38. Indoxyl sulfate promotes osteogenic differentiation of vascular smooth muscle cells by miR-155-5p-dependent downregulation of matrix Gla protein via ROS/NF-κB signaling.
He X; Wang Z; Wei L; Cheng X; Chen L; Gao F; Jiang H
Exp Cell Res; 2020 Dec; 397(1):112301. PubMed ID: 32979364
[TBL] [Abstract][Full Text] [Related]
39. Restoration of microRNA-30b expression alleviates vascular calcification through the mTOR signaling pathway and autophagy.
Xu TH; Qiu XB; Sheng ZT; Han YR; Wang J; Tian BY; Yao L
J Cell Physiol; 2019 Aug; 234(8):14306-14318. PubMed ID: 30701530
[TBL] [Abstract][Full Text] [Related]
40. Hyperphosphatemia-induced degradation of transcription factor EB exacerbates vascular calcification.
Ishiwata R; Morimoto Y
Biochim Biophys Acta Mol Basis Dis; 2022 Mar; 1868(3):166323. PubMed ID: 34921974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
